Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Testing effectiveness (Phase 2)Study completedNCT03365791What this trial is testingPDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic MalignanciesWho this might be right forSmall Cell Lung CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+5 more Novartis Pharmaceuticals 76
Early research (Phase 1)Study completedNCT03849469What this trial is testingXmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsWho this might be right forMelanomaCervical CarcinomaPancreatic Carcinoma+20 more Xencor, Inc. 78
Early research (Phase 1)Temporarily pausedNCT03970382What this trial is testingGene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid TumorsWho this might be right forSolid Tumor PACT Pharma, Inc. 21
Testing effectiveness (Phase 2)Study completedNCT05864144What this trial is testingSNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Study completedNCT00066404What this trial is testingIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsWho this might be right forCancer Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Looking for participantsNCT07177937What this trial is testingDXC014 in Patients With Advanced Solid Tumors.Who this might be right forSmall Cell Lung CancerMelanomaProstate Cancer+1 more Hangzhou DAC Biotechnology Co., Ltd. 150
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT01155258What this trial is testingTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsWho this might be right forExtensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more University of Southern California 19
Early research (Phase 1)Study completedNCT04148937What this trial is testingThe CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced CancerWho this might be right forAdvanced Cancer Eli Lilly and Company 52
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)WithdrawnNCT05582031What this trial is testingRegorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable CancersWho this might be right forAnal Squamous Cell CarcinomaColorectal NeoplasmsSoft Tissue Sarcoma+5 more Translational Research in Oncology
Early research (Phase 1)Looking for participantsNCT06242470What this trial is testingMGC026 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorAdvanced CancerMetastatic Cancer+19 more MacroGenics 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT04471727What this trial is testingA Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)Who this might be right forSmall-Cell Lung CancerNeuroendocrine Carcinoma Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 232
Testing effectiveness (Phase 2)Study completedNCT00333502What this trial is testingStudy of CRLX101 (NLG207) in the Treatment of Advanced Solid TumorsWho this might be right forCancerSolid Tumor NewLink Genetics Corporation 62
Early research (Phase 1)Ended earlyNCT06287463What this trial is testingStudy of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) PathwayWho this might be right forAdvanced Solid TumorRAF MutationRAS Mutation+7 more Deciphera Pharmaceuticals, LLC 29
Not applicableStudy completedNCT00428220What this trial is testingA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.Who this might be right forMetastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate Cancer+9 more Pfizer 223
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT03333616What this trial is testingNivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary TumorsWho this might be right forGenitourinary CancerAdrenocortical CarcinomaNon-urothelial Bladder+5 more Dana-Farber Cancer Institute 100